IDEXX LABORATORIES INC /DE Revenue From Contract With Customer Excluding Assessed Tax

• IDEXX LABORATORIES INC /DE showed an increase of +10.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from IDEXX LABORATORIES INC /DE's annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2017: $462.02 million | Q2 2017: $508.94 million | Q3 2017: $491.98 million | Q4 2017: $506.12 million | Q1 2018: $537.66 million | Q2 2018: $580.75 million | Q3 2018: $545.45 million | Q4 2018: $549.39 million | Q1 2019: $576.06 million | Q2 2019: $620.10 million | Q3 2019: $605.30 million | Q4 2019: $605.45 million | Q1 2020: $626.34 million | Q2 2020: $637.59 million | Q3 2020: $721.79 million | Q1 2021: $777.71 million | Q2 2021: $826.14 million | Q3 2021: $810.42 million | Q1 2022: $836.55 million | Q2 2022: $860.55 million | Q3 2022: $841.66 million | Q1 2023: $900.20 million | Q2 2023: $943.63 million | Q3 2023: $915.53 million | Q1 2024: $964.10 million | Q2 2024: $1.00 billion | Q3 2024: $975.54 million | Q1 2025: $998.43 million | Q2 2025: $1.11 billion | Q3 2025: $1.11 billion.
• Over the full 10 years of available data (2016 to 2025), IDEXX LABORATORIES INC /DE's Revenue From Contract With Customer Excluding Assessed Tax has grown by 142.4%.
• Historical annual values: Fiscal year 2025: $4.30 billion | Fiscal year 2024: $3.90 billion | Fiscal year 2023: $3.66 billion | Fiscal year 2022: $3.37 billion | Fiscal year 2021: $3.22 billion | Fiscal year 2020: $2.71 billion | Fiscal year 2019: $2.41 billion | Fiscal year 2018: $2.21 billion | Fiscal year 2017: $1.97 billion | Fiscal year 2016: $1.78 billion.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026